Skincel LLC develops a treatment method for a severe orphan skin disease, epidermolysis bullosa, based on the SPRS® therapy technology platform.
Services for medical centers on the use of medical technology of autologous dermal fibroblasts for the correction of age-related and scarring skin defects
Cellular skin correction
Innovative proprietary medical technology of using one’s own dermal fibroblasts to correct age-related and scar skin defects.
Synthesizing collagen, elastin, hyaluronic acid, and other components of the intercellular matrix, fibroblasts effectively restore the microstructure of the skin and stimulate the natural processes of its renewal.
Skin condition diagnosis
Unique personalized diagnostics of the regenerative and proliferative potential of the fibroblast population in the patient’s skin. Modern laboratory techniques make it possible to assess the quantity and morphology of the fibroblasts available in the skin, as well as their functional division ability.
An individual program is created for the patient to correct defects and prevent skin aging, also using cell therapy.
Restoration of periodontal tissues
Innovative medical technology for the restoration of soft periodontal tissues using autologous gingival dermal fibroblasts.
